Radiotherapy downregulates SIRT2 levels in breast cancer patients post-treatment, with pre-radiotherapy SIRT2 levels positively correlated with treatment response, suggesting SIRT2 as a potential predictive biomarker [126]. The gene discussed is SIRT2; the disease is breast carcinoma.